Bammann K, Peplies J, Pigeot I, Ahrens W [IDEFICS: a multicenter European project on diet- and lifestyle-related disorders in children]. Med Klin (Munich). 2007 Mar 15;102(3):230-5. doi: 10.1007/s00063-007-1027-2. German.
Freedman DS, Mei Z, Srinivasan SR, Berenson GS, Dietz WH Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr. 2007 Jan;150(1):12-17.e2. doi: 10.1016/j.jpeds.2006.08.042.
Golan M, Kaufman V, Shahar DR Childhood obesity treatment: targeting parents exclusively v. parents and children. Br J Nutr. 2006 May;95(5):1008-15. doi: 10.1079/bjn20061757.
Metcalf PA, Scragg RK, Stewart AW, Scott AJ Design effects associated with dietary nutrient intakes from a clustered design of 1 to 14-year-old children. Eur J Clin Nutr. 2007 Sep;61(9):1064-71. doi: 10.1038/sj.ejcn.1602618. Epub 2007 Jan 31.
Ogden CL, Flegal KM, Carroll MD, Johnson CL Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002 Oct 9;288(14):1728-32. doi: 10.1001/jama.288.14.1728.
Rodearmel SJ, Wyatt HR, Stroebele N, Smith SM, Ogden LG, Hill JO Small changes in dietary sugar and physical activity as an approach to preventing excessive weight gain: the America on the Move family study. Pediatrics. 2007 Oct;120(4):e869-79. doi: 10.1542/peds.2006-2927.
Singh AS, Mulder C, Twisk JW, van Mechelen W, Chinapaw MJ Tracking of childhood overweight into adulthood: a systematic review of the literature. Obes Rev. 2008 Sep;9(5):474-88. doi: 10.1111/j.1467-789X.2008.00475.x. Epub 2008 Mar 5.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
